NO153850C - Analogifremgangsmaate for fremstilling av terapeutisk aktive guanidiner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive guanidiner.

Info

Publication number
NO153850C
NO153850C NO801585A NO801585A NO153850C NO 153850 C NO153850 C NO 153850C NO 801585 A NO801585 A NO 801585A NO 801585 A NO801585 A NO 801585A NO 153850 C NO153850 C NO 153850C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogue procedure
guanidines
active guanidines
Prior art date
Application number
NO801585A
Other languages
English (en)
Norwegian (no)
Other versions
NO801585L (no
NO153850B (no
Inventor
Krishna G Dave
Thomas George
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO801585L publication Critical patent/NO801585L/no
Publication of NO153850B publication Critical patent/NO153850B/no
Publication of NO153850C publication Critical patent/NO153850C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO801585A 1979-05-29 1980-05-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive guanidiner. NO153850C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH499379 1979-05-29

Publications (3)

Publication Number Publication Date
NO801585L NO801585L (no) 1980-12-01
NO153850B NO153850B (no) 1986-02-24
NO153850C true NO153850C (no) 1986-06-04

Family

ID=4286083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801585A NO153850C (no) 1979-05-29 1980-05-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive guanidiner.

Country Status (21)

Country Link
US (1) US4626537A (hu)
EP (1) EP0020303B1 (hu)
JP (1) JPS55160764A (hu)
KR (2) KR840002309B1 (hu)
AT (1) ATE15189T1 (hu)
CS (2) CS220336B2 (hu)
CY (1) CY1442A (hu)
DD (1) DD151163A5 (hu)
DE (1) DE3071029D1 (hu)
DK (1) DK156059B (hu)
ES (1) ES491926A0 (hu)
FI (1) FI75154C (hu)
GR (1) GR68377B (hu)
HK (1) HK80788A (hu)
HU (1) HU183145B (hu)
IL (1) IL60161A (hu)
NO (1) NO153850C (hu)
PL (2) PL126790B1 (hu)
PT (1) PT71313A (hu)
SG (1) SG33688G (hu)
SU (2) SU1222191A3 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8312665D0 (en) * 1983-05-09 1983-06-15 Ici Plc 4,4'-alkylenedipiperidine derivatives
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
WO1994021621A1 (en) * 1993-03-23 1994-09-29 Astra Aktiebolag Guanidine derivatives useful in therapy
US6756389B2 (en) * 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
ATE478867T1 (de) * 2002-05-23 2010-09-15 Novartis Vaccines & Diagnostic Substituierte quinazolinone verbindungen
KR20060018217A (ko) 2003-05-23 2006-02-28 카이론 코포레이션 Mc4-r 작용제로서 구아니디노-치환된 퀴나졸리논 화합물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH513850A (de) * 1967-02-27 1971-10-15 Hoffmann La Roche Verfahren zur Herstellung von Pyrrolinverbindungen
DE2205744A1 (de) * 1972-02-08 1973-08-09 Thomae Gmbh Dr K Neue durch einen guanidinylidenrest substituierte heterocyclen und verfahren zu ihrer herstellung
US3840524A (en) * 1973-04-25 1974-10-08 Richardson Merrell Inc Alpha-cycloalkylbenzyl lactamimides
US4126611A (en) * 1973-08-09 1978-11-21 Richardson-Merrell Inc. Substituted cycloalkyl lactamimides
US4211867A (en) * 1976-03-19 1980-07-08 Mcneil Laboratories, Incorporated Nitrogen heterocyclic carboximidamide compounds
NZ183570A (en) * 1976-03-19 1979-06-08 Mcneilab Inc Heterocyclic guanidine derivatives, having anti-secretory and hypogliycaemic activity
CS225804B2 (cs) * 1976-03-19 1984-02-13 Mcneilab Inc Způsob výroby heterocyklických derivátů guanidinu

Also Published As

Publication number Publication date
JPS55160764A (en) 1980-12-13
SG33688G (en) 1989-01-27
KR840002309B1 (ko) 1984-12-17
FI801690A (fi) 1980-11-30
ES8103031A1 (es) 1981-02-16
CS220327B2 (en) 1983-03-25
CS220336B2 (en) 1983-03-25
HU183145B (en) 1984-04-28
US4626537A (en) 1986-12-02
DK229480A (da) 1980-11-30
GR68377B (hu) 1981-12-28
CY1442A (en) 1989-03-10
NO801585L (no) 1980-12-01
NO153850B (no) 1986-02-24
DD151163A5 (de) 1981-10-08
FI75154B (fi) 1988-01-29
DE3071029D1 (en) 1985-10-03
SU1222191A3 (ru) 1986-03-30
ATE15189T1 (de) 1985-09-15
SU1227111A3 (ru) 1986-04-23
ES491926A0 (es) 1981-02-16
PT71313A (de) 1980-06-01
FI75154C (fi) 1988-05-09
KR830002716A (ko) 1983-05-30
IL60161A (en) 1984-05-31
IL60161A0 (en) 1980-07-31
DK156059B (da) 1989-06-19
PL224523A1 (hu) 1981-02-13
PL124028B1 (en) 1982-12-31
EP0020303B1 (de) 1985-08-28
KR840002310B1 (ko) 1984-12-17
EP0020303A1 (de) 1980-12-10
HK80788A (en) 1988-10-14
PL126790B1 (en) 1983-08-31

Similar Documents

Publication Publication Date Title
ES8202799A1 (es) Procedimiento para la preparacion de sulfonilureas
IT8248200A0 (it) Preparato farmaceutico per la cura del diabete mellitus
ATE89547T1 (de) Dopamin-vorlaeufer.
FI854926A0 (fi) Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler.
NO153850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guanidiner.
NO155880C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-baa-fenylpropionfenon.
ATE66230T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
NO167978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
ES8105273A1 (es) Procedimiento para la obtencion de derivados de guanidina
IE800709L (en) Guanidines.
ES8500925A1 (es) "procedimiento para la preparacion de n-(2-(((5-(dimetilamino)-metil-2-furanil) metil) tio) etil) -n'- metil-2-nitro 1,1-etenodiamina"
ES8107219A1 (es) Procedimiento para la preparacion de sulfonilureas
PT71725A (de) 2-(2-chlor-4-cyclopropyl-phenyl-imino)-imidazolidin dessensaureadditionssalze diese enthaltende arzneimittel und verfahren zur herstellung derselben
NO903585D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
IL96683A0 (en) Imidazolyl propyl guanidine derivative,a process for its preparation and a pharmaceutical composition containing this compound
ES8303392A1 (es) Procedimiento para la obtencion de la n-2(5-dimetilamino) metil-2-furanil) metil tio etil-n-(2-etanol)-2-nitro-1,1-etenodiamina.